SEC ownership of Charming Medical Ltd

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0002035992.

Comparable stake leader

Kit Christine Wong

Disclosed value leader

Kit Christine Wong

Comparable rows

0/3

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0002035992
Issuer location
Hong Kong, Hong Kong

Ownership snapshot

Top shareholders of Charming Medical Ltd (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Kit Christine Wong
Disclosed value leader
Kit Christine Wong
Comparable rows
0/3
Latest evidence
30 Jun 2026
3/4/5 13F Highest disclosed value: $303,833,782 3 rows are not safely comparable across share classes.

Quick read

Kit Christine Wong has the largest disclosed position value at $303.83M.

0 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Kit Christine Wong's linked filing trail.
Disclosed position value Top 3
Kit Christine Wong $303.83M
UBS Group AG $711.8K
GEODE CAPITAL MANAGEMENT, LLC $315.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-3 of 3 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Kit Christine Wong
3/4/5
Chief Executive Officer, Director, 10%+ Owner
mixed-class rows
$303,833,782
12,350,360 shares
mixed-class rows
18 Mar 2026
UBS Group AG
13F
Company
13F
class O/S missing
$711,829
24,249 shares
30 Jun 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
class O/S missing
$315,624
10,752 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 18 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-3 of 3 reporting-owner rows connected to Charming Medical Ltd. Open a relationship link for the CIK-to-CIK filing trail.

Rows
3
Largest Forms 3/4/5 holder
Kit Christine Wong
Net 12M change
$0
Latest report
18 Mar 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Kit Christine Wong Chief Executive Officer, Director, 10%+ Owner $303,833,782 Mixed 18 Mar 2026
Shu Tai Victor Yu Director Mixed 18 Mar 2026
Ching Man Cheung Chief Financial Officer Mixed 18 Mar 2026

Recent insider transactions for Charming Medical Ltd

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Kit Christine Wong MCTA Class B ordinary shares, par value US$0.0001 per share 0 2,000,000 18 Mar 2026 Direct
Kit Christine Wong MCTA Class A ordinary shares, par value US$0.0001 per share 0 10,350,360 18 Mar 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .